Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Inter-patient variations of radiation-induced normal-tissue changes in Gd-EOB-DTPA-enhanced hepatic MRI scans during fractionated proton therapy.

Richter C, Andronesi OC, Borra RJH, Voigt F, Löck S, Duda DG, Guimaraes AR, Hong TS, Bortfeld TR, Seco J.

Clin Transl Radiat Oncol. 2019 Apr 26;18:113-119. doi: 10.1016/j.ctro.2019.04.013. eCollection 2019 Sep.

2.

Whole-slice mapping of GABA and GABA+ at 7T via adiabatic MEGA-editing, real-time instability correction, and concentric circle readout.

Moser P, Hingerl L, Strasser B, Považan M, Hangel G, Andronesi OC, van der Kouwe A, Gruber S, Trattnig S, Bogner W.

Neuroimage. 2019 Jan 1;184:475-489. doi: 10.1016/j.neuroimage.2018.09.039. Epub 2018 Sep 19.

PMID:
30243974
3.

Precision oncology in the era of radiogenomics: the case of D-2HG as an imaging biomarker for mutant IDH gliomas.

Andronesi OC.

Neuro Oncol. 2018 Jun 18;20(7):865-867. doi: 10.1093/neuonc/noy085. No abstract available.

4.

ACRIN 6684: Multicenter, phase II assessment of tumor hypoxia in newly diagnosed glioblastoma using magnetic resonance spectroscopy.

Ratai EM, Zhang Z, Fink J, Muzi M, Hanna L, Greco E, Richards T, Kim D, Andronesi OC, Mintz A, Kostakoglu L, Prah M, Ellingson B, Schmainda K, Sorensen G, Barboriak D, Mankoff D, Gerstner ER; ACRIN 6684 trial group.

PLoS One. 2018 Jun 14;13(6):e0198548. doi: 10.1371/journal.pone.0198548. eCollection 2018.

5.

Bone marrow drives central nervous system regeneration after radiation injury.

Dietrich J, Baryawno N, Nayyar N, Valtis YK, Yang B, Ly I, Besnard A, Severe N, Gustafsson KU, Andronesi OC, Batchelor TT, Sahay A, Scadden DT.

J Clin Invest. 2018 Jun 1;128(6):2651. doi: 10.1172/JCI121592. Epub 2018 Jun 1. No abstract available.

6.

Pharmacodynamics of mutant-IDH1 inhibitors in glioma patients probed by in vivo 3D MRS imaging of 2-hydroxyglutarate.

Andronesi OC, Arrillaga-Romany IC, Ly KI, Bogner W, Ratai EM, Reitz K, Iafrate AJ, Dietrich J, Gerstner ER, Chi AS, Rosen BR, Wen PY, Cahill DP, Batchelor TT.

Nat Commun. 2018 Apr 16;9(1):1474. doi: 10.1038/s41467-018-03905-6.

7.

Radiomics, Metabolic, and Molecular MRI for Brain Tumors.

Kickingereder P, Andronesi OC.

Semin Neurol. 2018 Feb;38(1):32-40. doi: 10.1055/s-0037-1618600. Epub 2018 Mar 16. Review.

PMID:
29548050
8.

Bone marrow drives central nervous system regeneration after radiation injury.

Dietrich J, Baryawno N, Nayyar N, Valtis YK, Yang B, Ly I, Besnard A, Severe N, Gustafsson KU, Andronesi OC, Batchelor TT, Sahay A, Scadden DT.

J Clin Invest. 2018 Jan 2;128(1):281-293. doi: 10.1172/JCI90647. Epub 2017 Dec 4. Erratum in: J Clin Invest. 2018 Jun 1;128(6):2651.

9.

Early changes in glioblastoma metabolism measured by MR spectroscopic imaging during combination of anti-angiogenic cediranib and chemoradiation therapy are associated with survival.

Andronesi OC, Esmaeili M, Borra RJH, Emblem K, Gerstner ER, Pinho MC, Plotkin SR, Chi AS, Eichler AF, Dietrich J, Ivy SP, Wen PY, Duda DG, Jain R, Rosen BR, Sorensen GA, Batchelor TT.

NPJ Precis Oncol. 2017;1. pii: 20. doi: 10.1038/s41698-017-0020-3. Epub 2017 Jun 12.

10.

Isocitrate dehydrogenase-mutant glioma: Evolving clinical and therapeutic implications.

Miller JJ, Shih HA, Andronesi OC, Cahill DP.

Cancer. 2017 Dec 1;123(23):4535-4546. doi: 10.1002/cncr.31039. Epub 2017 Oct 5. Review.

11.

Real-time Correction of Motion and Imager Instability Artifacts during 3D γ-Aminobutyric Acid-edited MR Spectroscopic Imaging.

Heckova E, Považan M, Strasser B, Krumpolec P, Hnilicová P, Hangel GJ, Moser PA, Andronesi OC, van der Kouwe AJ, Valkovic P, Ukropcova B, Trattnig S, Bogner W.

Radiology. 2018 Feb;286(2):666-675. doi: 10.1148/radiol.2017170744. Epub 2017 Sep 28.

12.

1D-spectral editing and 2D multispectral in vivo1H-MRS and 1H-MRSI - Methods and applications.

Bogner W, Hangel G, Esmaeili M, Andronesi OC.

Anal Biochem. 2017 Jul 15;529:48-64. doi: 10.1016/j.ab.2016.12.020. Epub 2016 Dec 26. Review.

13.

Dynamic 31 P-MRSI using spiral spectroscopic imaging can map mitochondrial capacity in muscles of the human calf during plantar flexion exercise at 7 T.

Valkovič L, Chmelík M, Meyerspeer M, Gagoski B, Rodgers CT, Krššák M, Andronesi OC, Trattnig S, Bogner W.

NMR Biomed. 2016 Dec;29(12):1825-1834. doi: 10.1002/nbm.3662. Epub 2016 Nov 8.

14.

Spatial variability and reproducibility of GABA-edited MEGA-LASER 3D-MRSI in the brain at 3 T.

Hnilicová P, Považan M, Strasser B, Andronesi OC, Gajdošík M, Dydak U, Ukropec J, Dobrota D, Trattnig S, Bogner W.

NMR Biomed. 2016 Nov;29(11):1656-1665. doi: 10.1002/nbm.3613. Epub 2016 Oct 7.

15.

Volumetric relationship between 2-hydroxyglutarate and FLAIR hyperintensity has potential implications for radiotherapy planning of mutant IDH glioma patients.

Jafari-Khouzani K, Loebel F, Bogner W, Rapalino O, Gonzalez GR, Gerstner E, Chi AS, Batchelor TT, Rosen BR, Unkelbach J, Shih HA, Cahill DP, Andronesi OC.

Neuro Oncol. 2016 Nov;18(11):1569-1578. Epub 2016 Jul 5.

16.

Three-dimensional MR spectroscopic imaging using adiabatic spin echo and hypergeometric dual-band suppression for metabolic mapping over the entire brain.

Esmaeili M, Bathen TF, Rosen BR, Andronesi OC.

Magn Reson Med. 2017 Feb;77(2):490-497. doi: 10.1002/mrm.26115. Epub 2016 Feb 2.

17.

Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate.

Andronesi OC, Loebel F, Bogner W, Marjańska M, Vander Heiden MG, Iafrate AJ, Dietrich J, Batchelor TT, Gerstner ER, Kaelin WG, Chi AS, Rosen BR, Cahill DP.

Clin Cancer Res. 2016 Apr 1;22(7):1632-41. doi: 10.1158/1078-0432.CCR-15-0656. Epub 2015 Nov 3.

18.

In vivo brain rosette spectroscopic imaging (RSI) with LASER excitation, constant gradient strength readout, and automated LCModel quantification for all voxels.

Schirda CV, Zhao T, Andronesi OC, Lee Y, Pan JW, Mountz JM, Hetherington HP, Boada FE.

Magn Reson Med. 2016 Aug;76(2):380-90. doi: 10.1002/mrm.25896. Epub 2015 Aug 26.

19.

3D GABA imaging with real-time motion correction, shim update and reacquisition of adiabatic spiral MRSI.

Bogner W, Gagoski B, Hess AT, Bhat H, Tisdall MD, van der Kouwe AJW, Strasser B, Marjańska M, Trattnig S, Grant E, Rosen B, Andronesi OC.

Neuroimage. 2014 Dec;103:290-302. doi: 10.1016/j.neuroimage.2014.09.032. Epub 2014 Sep 26.

20.

Whole brain mapping of water pools and molecular dynamics with rotating frame MR relaxation using gradient modulated low-power adiabatic pulses.

Andronesi OC, Bhat H, Reuter M, Mukherjee S, Caravan P, Rosen BR.

Neuroimage. 2014 Apr 1;89:92-109. doi: 10.1016/j.neuroimage.2013.12.007. Epub 2013 Dec 15.

21.

Slice accelerated gradient-echo spin-echo dynamic susceptibility contrast imaging with blipped CAIPI for increased slice coverage.

Eichner C, Jafari-Khouzani K, Cauley S, Bhat H, Polaskova P, Andronesi OC, Rapalino O, Turner R, Wald LL, Stufflebeam S, Setsompop K.

Magn Reson Med. 2014 Sep;72(3):770-8. doi: 10.1002/mrm.24960. Epub 2013 Oct 28.

22.

Real-time motion- and B0-correction for LASER-localized spiral-accelerated 3D-MRSI of the brain at 3T.

Bogner W, Hess AT, Gagoski B, Tisdall MD, van der Kouwe AJ, Trattnig S, Rosen B, Andronesi OC.

Neuroimage. 2014 Mar;88:22-31. doi: 10.1016/j.neuroimage.2013.09.034. Epub 2013 Nov 5.

23.

Detection of oncogenic IDH1 mutations using magnetic resonance spectroscopy of 2-hydroxyglutarate.

Andronesi OC, Rapalino O, Gerstner E, Chi A, Batchelor TT, Cahill DP, Sorensen AG, Rosen BR.

J Clin Invest. 2013 Sep;123(9):3659-63. doi: 10.1172/JCI67229. Epub 2013 Sep 3. Review.

24.

Feasibility study of in vivo MRI based dosimetric verification of proton end-of-range for liver cancer patients.

Yuan Y, Andronesi OC, Bortfeld TR, Richter C, Wolf R, Guimaraes AR, Hong TS, Seco J.

Radiother Oncol. 2013 Mar;106(3):378-82. doi: 10.1016/j.radonc.2013.01.016. Epub 2013 Mar 7.

PMID:
23473960
25.

From genomics to the clinic: biological and translational insights of mutant IDH1/2 in glioma.

Dunn GP, Andronesi OC, Cahill DP.

Neurosurg Focus. 2013 Feb;34(2):E2. doi: 10.3171/2012.12.FOCUS12355. Review.

PMID:
23373447
26.

Heterogeneous data fusion for brain tumor classification.

Metsis V, Huang H, Andronesi OC, Makedon F, Tzika A.

Oncol Rep. 2012 Oct;28(4):1413-6. doi: 10.3892/or.2012.1931. Epub 2012 Jul 25.

PMID:
22842996
27.

Detection of 2-hydroxyglutarate in IDH-mutated glioma patients by in vivo spectral-editing and 2D correlation magnetic resonance spectroscopy.

Andronesi OC, Kim GS, Gerstner E, Batchelor T, Tzika AA, Fantin VR, Vander Heiden MG, Sorensen AG.

Sci Transl Med. 2012 Jan 11;4(116):116ra4. doi: 10.1126/scitranslmed.3002693.

28.

Neurologic 3D MR spectroscopic imaging with low-power adiabatic pulses and fast spiral acquisition.

Andronesi OC, Gagoski BA, Sorensen AG.

Radiology. 2012 Feb;262(2):647-61. doi: 10.1148/radiol.11110277. Epub 2011 Dec 20.

29.

Real-time motion and B0 correction for localized adiabatic selective refocusing (LASER) MRSI using echo planar imaging volumetric navigators.

Hess AT, Andronesi OC, Tisdall MD, Sorensen AG, van der Kouwe AJ, Meintjes EM.

NMR Biomed. 2012 Feb;25(2):347-58. doi: 10.1002/nbm.1756. Epub 2011 Jul 28.

30.

Correlation chemical shift imaging with low-power adiabatic pulses and constant-density spiral trajectories.

Andronesi OC, Gagoski BA, Adalsteinsson E, Sorensen AG.

NMR Biomed. 2012 Feb;25(2):195-209. doi: 10.1002/nbm.1730. Epub 2011 Jul 20.

31.

Serial magnetic resonance spectroscopy reveals a direct metabolic effect of cediranib in glioblastoma.

Kim H, Catana C, Ratai EM, Andronesi OC, Jennings DL, Batchelor TT, Jain RK, Sorensen AG.

Cancer Res. 2011 Jun 1;71(11):3745-52. doi: 10.1158/0008-5472.CAN-10-2991. Epub 2011 Apr 20.

32.

In vivo 31P spectroscopy by fully adiabatic extended image selected in vivo spectroscopy: a comparison between 3 T and 7 T.

Bogner W, Chmelik M, Andronesi OC, Sorensen AG, Trattnig S, Gruber S.

Magn Reson Med. 2011 Oct;66(4):923-30. doi: 10.1002/mrm.22897. Epub 2011 Mar 28.

33.

Real-time motion and B0 corrected single voxel spectroscopy using volumetric navigators.

Hess AT, Tisdall MD, Andronesi OC, Meintjes EM, van der Kouwe AJ.

Magn Reson Med. 2011 Aug;66(2):314-23. doi: 10.1002/mrm.22805. Epub 2011 Mar 4.

34.

Use of in vivo two-dimensional MR spectroscopy to compare the biochemistry of the human brain to that of glioblastoma.

Ramadan S, Andronesi OC, Stanwell P, Lin AP, Sorensen AG, Mountford CE.

Radiology. 2011 May;259(2):540-9. doi: 10.1148/radiol.11101123. Epub 2011 Feb 25.

35.

Combining magnetic resonance spectroscopy and molecular genomics offers better accuracy in brain tumor typing and prediction of survival than either methodology alone.

Astrakas L, Blekas KD, Constantinou C, Andronesi OC, Mindrinos MN, Likas AC, Rahme LG, Black PM, Marcus KJ, Tzika AA.

Int J Oncol. 2011 Apr;38(4):1113-27. doi: 10.3892/ijo.2011.928. Epub 2011 Jan 27.

PMID:
21274507
36.

Glioblastoma recurrence after cediranib therapy in patients: lack of "rebound" revascularization as mode of escape.

di Tomaso E, Snuderl M, Kamoun WS, Duda DG, Auluck PK, Fazlollahi L, Andronesi OC, Frosch MP, Wen PY, Plotkin SR, Hedley-Whyte ET, Sorensen AG, Batchelor TT, Jain RK.

Cancer Res. 2011 Jan 1;71(1):19-28. doi: 10.1158/0008-5472.CAN-10-2602. Erratum in: Cancer Res. 2011 Mar 15;71(6):2405.

37.

Combined off-resonance imaging and T2 relaxation in the rotating frame for positive contrast MR imaging of infection in a murine burn model.

Andronesi OC, Mintzopoulos D, Righi V, Psychogios N, Kesarwani M, He J, Yasuhara S, Dai G, Rahme LG, Tzika AA.

J Magn Reson Imaging. 2010 Nov;32(5):1172-83. doi: 10.1002/jmri.22349. Erratum in: J Magn Reson Imaging. 2011 Jan;33(1):256. Righi, Valeria [added].

38.

Low-power adiabatic sequences for in vivo localized two-dimensional chemical shift correlated MR spectroscopy.

Andronesi OC, Ramadan S, Mountford CE, Sorensen AG.

Magn Reson Med. 2010 Dec;64(6):1542-56. doi: 10.1002/mrm.22535. Epub 2010 Oct 1.

39.

Spectroscopic imaging with improved gradient modulated constant adiabaticity pulses on high-field clinical scanners.

Andronesi OC, Ramadan S, Ratai EM, Jennings D, Mountford CE, Sorensen AG.

J Magn Reson. 2010 Apr;203(2):283-93. doi: 10.1016/j.jmr.2010.01.010. Epub 2010 Jan 28.

40.

High-resolution magic angle spinning magnetic resonance spectroscopy detects glycine as a biomarker in brain tumors.

Righi V, Andronesi OC, Mintzopoulos D, Black PM, Tzika AA.

Int J Oncol. 2010 Feb;36(2):301-6.

41.

Molecular classification of brain tumor biopsies using solid-state magic angle spinning proton magnetic resonance spectroscopy and robust classifiers.

Andronesi OC, Blekas KD, Mintzopoulos D, Astrakas L, Black PM, Tzika AA.

Int J Oncol. 2008 Nov;33(5):1017-25.

42.

Solid-state NMR adiabatic TOBSY sequences provide enhanced sensitivity for multidimensional high-resolution magic-angle-spinning 1H MR spectroscopy.

Andronesi OC, Mintzopoulos D, Struppe J, Black PM, Tzika AA.

J Magn Reson. 2008 Aug;193(2):251-8. doi: 10.1016/j.jmr.2008.05.017. Epub 2008 May 27.

PMID:
18556227
43.

Characterization of Alzheimer's-like paired helical filaments from the core domain of tau protein using solid-state NMR spectroscopy.

Andronesi OC, von Bergen M, Biernat J, Seidel K, Griesinger C, Mandelkow E, Baldus M.

J Am Chem Soc. 2008 May 7;130(18):5922-8. doi: 10.1021/ja7100517. Epub 2008 Apr 3.

PMID:
18386894
44.

Structural characterization of Ca(2+)-ATPase-bound phospholamban in lipid bilayers by solid-state nuclear magnetic resonance (NMR) spectroscopy.

Seidel K, Andronesi OC, Krebs J, Griesinger C, Young HS, Becker S, Baldus M.

Biochemistry. 2008 Apr 15;47(15):4369-76. doi: 10.1021/bi7024194. Epub 2008 Mar 21.

PMID:
18355039
45.

Combination of high-resolution magic angle spinning proton magnetic resonance spectroscopy and microscale genomics to type brain tumor biopsies.

Tzika AA, Astrakas L, Cao H, Mintzopoulos D, Andronesi OC, Mindrinos M, Zhang J, Rahme LG, Blekas KD, Likas AC, Galatsanos NP, Carroll RS, Black PM.

Int J Mol Med. 2007 Aug;20(2):199-208.

PMID:
17611638
46.

Secondary structure, dynamics, and topology of a seven-helix receptor in native membranes, studied by solid-state NMR spectroscopy.

Etzkorn M, Martell S, Andronesi OC, Seidel K, Engelhard M, Baldus M.

Angew Chem Int Ed Engl. 2007;46(3):459-62. No abstract available.

PMID:
17001715
47.

Probing structure in the polymorphic domain of the L-enantiomer of N-benzoyl-phenylalanine by means of 2D solid-state NMR spectroscopy and DFT calculations.

Hughes CE, Olejniczak S, Helinski J, Ciesielski W, Repisky M, Andronesi OC, Potrzebowski MJ, Baldus M.

J Phys Chem B. 2005 Dec 15;109(49):23175-82.

PMID:
16375280
48.

Molecular-level secondary structure, polymorphism, and dynamics of full-length alpha-synuclein fibrils studied by solid-state NMR.

Heise H, Hoyer W, Becker S, Andronesi OC, Riedel D, Baldus M.

Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):15871-6. Epub 2005 Oct 24.

49.

Determination of membrane protein structure and dynamics by magic-angle-spinning solid-state NMR spectroscopy.

Andronesi OC, Becker S, Seidel K, Heise H, Young HS, Baldus M.

J Am Chem Soc. 2005 Sep 21;127(37):12965-74.

PMID:
16159291
50.

Probing membrane protein orientation and structure using fast magic-angle-spinning solid-state NMR.

Andronesi OC, Pfeifer JR, Al-Momani L, Ozdirekcan S, Rijkers DT, Angerstein B, Luca S, Koert U, Killian JA, Baldus M.

J Biomol NMR. 2004 Nov;30(3):253-65.

PMID:
15754053

Supplemental Content

Loading ...
Support Center